Regeneron (REGN) - News Mentions

Sign up to add (REGN) to your portfolio and access more historical data.

0 100%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 0 0%
Gilead Sciences
Gilead Sciences
GILD		 2 0%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 0 0%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 0 100%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 0 0%
Caprock Group LLC Cuts Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
November 21
Regeneron Pharmaceuticals, Inc. (REGN): Among the Best Genomics Stocks to Buy Right Now
November 19
Regeneron Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors
November 19
Regeneron Pharmaceuticals, Inc. (REGN) Jefferies London Healthcare Conference (Transcript)
November 19
Regeneron: The Biotech Stock To Buy Now
November 18
Wolfe Research Initiates Coverage on Regeneron Pharmaceuticals (NASDAQ:REGN)
November 18
Here’s Why Regeneron Pharmaceuticals (REGN) Declined in Q3
November 18
FDA Accepts SNY and REGN's Dupixent Re-Submitted sBLA for Urticaria
November 18
Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day
November 18
Regeneron Pharmaceuticals (NASDAQ:REGN) Upgraded at Wolfe Research
November 17
Regeneron Pharmaceuticals, Inc. - Dupixent sBLA Accepted for FDA Review for the Treatment of Chronic Spontaneous Urticaria
November 17
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Rating Upgraded by Citigroup
November 15
FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease
November 15
FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
November 15
Apollon Wealth Management LLC Lowers Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
November 15
Regeneron Pharmaceuticals Inc. stock outperforms competitors despite losses on the day
November 15

Month over Month

Est. daily news mentions.

Oct 2024 1
Sep 2024 1
Aug 2024 1
Jul 2024 1
Jun 2024 1

How often is Regeneron mentioned in the news?

Regeneron was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Regeneron performing compared to its industry peers?

Regeneron underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of Regeneron in the last month?

Regeneron's was mentioned in fewer articles yesterday, compared to the same day last month.

Why is it important to track news mentions for Regeneron?

By monitoring mentions in the news for Regeneron, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Regeneron, ultimately improving their investment strategies.

Sign up and get more insights on Regeneron.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact